Effect of atorvastatin therapy on borderline vulnerable lesions in patients with acute coronary syndrome

Archives of Medical Science

Volumn 7, Issue 3, 2011, Pages 433-439

  Yu, Dan Qing ^a   Lin, Shu Guang ^a   Chen, Ji Yan ^a   Xue, Ling ^a   Li, Guang ^a   Dong, Hao Jian ^a   Zhou, Ying Ling ^a  

^a Department of Cardiology   (China)

Author keywords

Acute coronary syndrome; Atorvastatin; Intravascular ultrasound; Vulnerable plaque

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; C REACTIVE PROTEIN; GELATINASE B; GLYCERYL TRINITRATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BORDERLINE VULNERABLE LESION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART INJURY; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; VASOSPASM;

EID: 79960451854     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.23408     Document Type: Article

References (32)

1. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000; 21: 1406-32. (Pubitemid 30636321)
2. Dokainish H, Pillai M, Murphy SA, et al.; TACTICS-TIMI-18 Investigators. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 2005; 45: 19-24. (Pubitemid 40052020)
3. von Korn H, Graefe V, Ohlow MA, et al. Acute coronary syndrome without significant stenosis on angiography: characteristics and prognosis. Tex Heart Inst J 2008; 35: 406-12.
4. Stadius ML, Alderman EL. Coronary artery revascularization. Critical need for, and consequences of, objective angiographic assessment of lesion severity. Circulation 1990; 82: 2231-4.
5. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: e166-286.
6. Reilly SD, Litovsky SH, Steinkampf MP, Caulfield JB. Statins improve human coronary atherosclerotic plaque morphology. Tex Heart Inst J 2008; 35: 99-103. (Pubitemid 351988635)
7. Legutko J, Dudek D, Chyrchel M, et al. Safety and effectiveness of pharmacologic versus mechanical stabilization of borderline coronary lesions in patients with acute coronary syndromes. Przegl Lek 2005; 62: 1-7.
8. Norell MS, Perrins J, Meier B, Lincoff AM. Essential interventional cardiology. Saunders/Elsevier, Philadelphia 2008; 46-9.
9. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 2001; 37: 1478-92.
10. Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995; 25: 1479-85.
11. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003; 107: 2072-5. (Pubitemid 36532184)
12. Wang CY, Liao JK. Current advances in statin treatment: from molecular mechanisms to clinical practice. Arch Med Sci 2007; 3 (Suppl 4A): S91-6.
13. Kumar A, Cannon CP. The current role of statins in acute coronary syndrome. Arch Med Sci 2007; 3 (Suppl 4A): S115-25.
14. Nissen SE, Nicholls SJ, Sipahi I, et al.; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006; 295: 1556-65.
15. Hiro T, Kimura T, Morimoto T, et al.; JAPAN-ACS Investigators. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 2009; 54: 293-302.
16. Sacks FM. Do statins play a role in the early management of the acute coronary syndrome? Eur Heart J Suppl 2004; 6 (Suppl A): A32-6.
17. Okazaki S, Yokoyama T, Miyauchi K, et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 2004; 110: 1061-8. (Pubitemid 39319003)
18. Brunzell JD, Davidson M, Furberg CD, et al.; American Diabetes Association; American College of Cardiology Foundation. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008; 31: 811-22.
19. Maki KC, Davidson MH, Dicklin MR. A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey. Can J Cardiol 2006; 22: 315-22.
20. McQueen MJ, Hawken S, Wang X, et al.; INTERHEART study investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008; 372: 224-33.
21. Panayiotou A, Griffin M, Georgiou N, et al. ApoB/ApoA1 ratio and subclinical atherosclerosis. Int Angiol 2008; 27: 74-80. (Pubitemid 351523671)
22. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med 2006; 259: 493-519.
23. Sierra-Johnson J, Fisher RM, Romero-Corral A, et al. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J 2009; 30: 710-7.
24. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009; 265: 275-87.
25. Emerging Risk Factors Collaboration, Danesh J, Erqou S, Walker M, et al. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007; 22: 839-69.
26. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984; 25: 1277-94. (Pubitemid 15150638)
27. Yip HK, Wu CJ, Hang CL, et al. Levels and values of inflammatory markers in patients with angina pectoris. Int Heart J 2005; 46: 571-81.
28. Nomoto K, Oguchi S, Watanabe I, Kushiro T, Kanmatsuse K. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-I. J Cardiol 2003; 42: 201-6. (Pubitemid 40756071)
29. th ed. Elsevier Saunders, Philadelphia 2005; 423-55.
30. De Scheerder I, De Man F, Herregods MC, et al. Intravascular ultrasound versus angiography for measurement of luminal diameters in normal and diseased coronary arteries. Am Heart J 1994; 127: 243-51. (Pubitemid 24063213)
31. Nishioka T, Amanullah AM, Luo H, et al. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: comparison with stress myocardial perfusion imaging. J Am Coll Cardiol 1999; 33: 1870-8.
32. Abizaid A, Pichard AD, Mintz GS, et al. Intravascular-ultrasound-guided percutaneous transluminal coronary angioplasty/provisional stent implantation strategy: impact on long-term clinical follow-up. Int J Cardiovasc Intervent 2001; 4: 107-14. (Pubitemid 33150882)